Hafrun Fridriksdottir, Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 348 shares at $17.88 ($6K) on 2018-03-19, disclosed to the SEC on 2018-03-20.
Open-market sale of $6k TEVA by Executive VP, Global R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.88 | 91 | $2K | 26.1% |
| 2 | $17.88 | 257 | $5K | 73.9% |
| Total | $17.88 avg | 348 | $6K | 100% |
| Filing → |
| TEVA | SELL | 2022-03-02 | $124K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $111K | — | Filing → |
| TEVA | SELL | 2021-08-12 | $1.0M | — | Filing → |